Systematic review of ixabepilone for treating metastatic breast cancer Jing LiJing RenWenxia Sun Review Article 04 August 2016 Pages: 171 - 179
DuCLOX-2/5 inhibition: a promising target for cancer chemoprevention Swetlana GautamSubhadeep RoyGaurav Kaithwas Review Article 24 August 2016 Pages: 180 - 190
Recent development of targeted approaches for the treatment of breast cancer V. L. MaruthanilaR. ElancheranJibon Kotoky Review Article 31 October 2016 Pages: 191 - 219
Gastrointestinal microbiome and breast cancer: correlations, mechanisms and potential clinical implications Jiqiao YangQiuwen TanQing Lv Review Article 05 October 2016 Pages: 220 - 228
Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population Salma ParvinMd. Siddiqul IslamAbul Hasnat Original Article 11 April 2016 Pages: 229 - 237
Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families Aouatef RiahiMohamel el GhourabiHabiba Chaabouni-Bouhamed Original Article 30 March 2016 Pages: 238 - 244
Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastases Arisa NishimukaiTomoko HiguchiYasuo Miyoshi Original Article 04 April 2016 Pages: 245 - 253
N-acetyltransferase 2 polymorphism and breast cancer risk with smoking: a case control study in Japanese women Akio HaraNaruto TairaShinichiro Miyoshi Original Article 11 April 2016 Pages: 254 - 262
A unique hypofractionated radiotherapy schedule with 51.3 Gy in 18 fractions three times per week for early breast cancer: outcomes including local control, acute and late skin toxicity Kouloulias VassilisGogalis IoannisKouvaris John Original Article 19 April 2016 Pages: 263 - 270
Combination of lapatinib with isothiocyanates overcomes drug resistance and inhibits migration of HER2 positive breast cancer cells Angelika KaczyńskaAnna Herman-Antosiewicz Original Article Open access 06 May 2016 Pages: 271 - 280
Which patient- and physician-related factors are associated with guideline adherent initiation of adjuvant endocrine therapy? Results of the prospective multi-centre cohort study BRENDA II Tanja StüberReyn van EwijkLukas Schwentner Original Article 19 May 2016 Pages: 281 - 287
Development of a Japanese version of the BREAST-Q and the traditional psychometric test of the mastectomy module for the assessment of HRQOL and patient satisfaction following breast surgery Miho SaigaNaruto TairaHiroyoshi Doihara Original Article 14 May 2016 Pages: 288 - 298
Anticancer effects of synthetic hexahydrobenzo [g]chromen-4-one derivatives on human breast cancer cell lines Mahboobeh PordeliMaryam NakhjiriAlireza Foroumadi Original Article 01 June 2016 Pages: 299 - 311
Assessment of left ventricular diastolic function during trastuzumab treatment in patients with HER2-positive breast cancer Kazunori HondaKyosuke TakeshitaYuichi Ando Original Article 27 May 2016 Pages: 312 - 318
Pretreatment quality of life, performance status and their relation to treatment discontinuation and treatment changes in high-risk breast cancer patients receiving chemotherapy: results from the prospective randomized ADEBAR trial Martin EichlerSusanne SingerLukas Schwentner Original Article 04 June 2016 Pages: 319 - 325
KLF4 and NANOG are prognostic biomarkers for triple-negative breast cancer Takuya NagataYutaka ShimadaKazuhiro Tsukada Original Article 14 June 2016 Pages: 326 - 335
OLA1 gene sequencing in patients with BRCA1/2 mutation-negative suspected hereditary breast and ovarian cancer Masanobu TakahashiNatsuko ChibaChikashi Ishioka Original Article 06 June 2016 Pages: 336 - 340
Patterns of clinical practice for sentinel lymph node biopsy in women with node-negative breast cancer: the results of a national survey in Japan Takafumi IkedaTomoharu SugieMasakazu Toi Rapid Communication 27 August 2016 Pages: 341 - 344
